O Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Sedež251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ustanovljeno2018
StatusAktivno

Patenti1 patent

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Išči vse patente na Heelky →

Ocene

Mnenj še ni. Ste sodelovali s Assertio Therapeutics, Inc.? Bodite prvi, ki deli izkušnjo.

Napišite mnenje →

Lokacija

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Je to vaše podjetje?

To stran brezplačno prevzemite, da dodate logotip, izdelke, fotografije in zaposlitve ter odgovorite na mnenja.

Prevzemite to stran

Deli to podjetje

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Kopiraj povezavo

Deli na

Koda QR

Skenirajte jo s fotoaparatom telefona, da odprete to stran, ali jo prenesite za letak, prosojnico ali značko.

Pridružite se Heelky, da se povežete, zaposlite in rastete

Ustvarite brezplačen račun, da ljudem pišete, se prijavljate na zaposlitve in objavljate misije.

Pridruži se zdaj — brezplačno je

Izberite jezik

Heelky si bo zapomnil vašo izbiro.

Drugi jeziki

Razpoložljivi jeziki: 70 O jezikih na Heelky